Showing results (1191-1200 of 3,660) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|July 19, 2016
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancerD Andreis, S Bonardi, G Allevi, et al.
Breast (Edinburgh, Scotland)|July 19, 2016
The impact of tamoxifen brand switch on side effects and patient compliance in hormone receptor positive breast cancer patientsB Zeidan, K Anderson, L Peiris, et al.
Breast (Edinburgh, Scotland)|August 1, 2016
Formal analysis of the surgical pathway and development of a new software tool to assist surgeons in the decision making in primary breast surgeryGiuseppe Catanuto, Francesco Pappalardo, Nicola Rocco, et al.
Breast (Edinburgh, Scotland)|August 1, 2016
Treatment of the benign inverted nipple: A systematic review and recommendations for future therapyQ M Hernandez Yenty, W J F M Jurgens, P P M van Zuijlen, et al.
Breast (Edinburgh, Scotland)|August 1, 2016
Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapyM C De Santis, F Bonfantini, F Di Salvo, et al.
Breast (Edinburgh, Scotland)|July 21, 2015
Medication taking behaviors among breast cancer patients on adjuvant endocrine therapyGretchen Kimmick, Sara N Edmond, Hayden B Bosworth, et al.
Breast (Edinburgh, Scotland)|July 26, 2016
Over-treatment in metastatic breast cancerElżbieta Senkus, Aleksandra Łacko
Breast (Edinburgh, Scotland)|April 29, 2020
Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical studyAntonio Di Meglio, Stefan Michiels, Lee W Jones, et al.
Breast (Edinburgh, Scotland)|October 6, 2007
The sentinel node biopsy under local anesthesia in breast cancer: advantages and problems, how the technique influenced the activity of a breast surgery department; update from the European Institute of Oncology with more than 1000 casesAlberto Luini, Pietro Caldarella, Giovanna Gatti, et al.
Breast (Edinburgh, Scotland)|October 3, 2006
Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor responseA Rody, T Karn, R Gätje, et al.
Pageof 366